Rating Change
Stifel analysts initiated coverage on Immatics N.V. (NASDAQ:IMTX) with a rating of Buy on October 14, 2026.
Stifel analysts initiated coverage on Immatics N.V. (NASDAQ:IMTX) with a rating of Buy on October 14, 2026.

At publication ·
Immatics N.V. (NASDAQ:IMTX) · new coverage
At a glance
Stifel analysts initiated coverage on Immatics N.V. (NASDAQ:IMTX) with a rating of Buy on October 14, 2026.
Immatics N.V. operates in the Healthcare sector. The stock currently trades at $6.96 with a market capitalization of $1.2B. The stock has declined 32.8% over the past 52 weeks.
Analyst coverage from Stifel provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Immatics N.V.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 14, 2026 | Stifel | Buy | N/A |
| May 19, 2026 | Chardan Capital | Buy | N/A |
| Apr 28, 2026 | TD Cowen | Buy | N/A |
| Nov 24, 2025 | Chardan Capital | Buy | N/A |
| Nov 19, 2025 | Mizuho | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View IMTX Stock Page
A rating of Buy from Stifel reflects the analyst's outlook on Immatics N.V. (NASDAQ:IMTX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the IMTX forecast page.
Current market data
NASDAQ · IMTX
Keep reading